CD5-targeted CAR-NK therapy

CD5-targeted chimeric antigen receptor natural killer cells · Chongqing Precision Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD5-targeted CAR-NK therapy, covering 2025-04-03 to 2025-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies [Phase 1]